Accolade Partners is a fund of funds established in 2000, specializing in venture capital and growth equity investments within the technology and healthcare sectors. They manage assets for various institutional and individual clients.
Key people at Accolade Partners.
Accolade Partners is a Washington, D.C.-based alternative investment firm founded in 2000 that manages approximately $5.8 billion across various strategies. Its mission is to deliver superior returns by investing in top-tier venture capital and private equity growth funds on behalf of endowments, foundations, family offices, institutions, and individual investors. The firm focuses primarily on U.S. fund managers in the technology and healthcare sectors, with additional allocations to blockchain and empowerment strategies. Accolade constructs highly selective, concentrated portfolios of hard-to-access funds, including early-stage venture capital and growth equity, aiming to provide investors exposure to difficult-to-access private markets. The firm also pursues direct investments alongside its fund managers, emphasizing bootstrapped, profitable companies distinct from late-stage venture capital. Accolade’s impact on the startup ecosystem is through its support of emerging and established fund managers, enabling capital flow into innovative technology and healthcare ventures[1][2][3][4].
Accolade Partners was founded in 2000 in Washington, D.C. Since inception, it has evolved from a general fund of funds manager to a firm with dedicated strategies in private equity growth, venture capital, blockchain, and empowerment funds. Key partners include Managing Partner Atul Rustgi and COO Andrew Salembier, who have guided the firm’s strategic expansions, such as launching a dedicated PE growth fund of funds in 2019 and a venture capital-only fund of funds more recently. The firm’s early recognition of opportunities in PE growth and venture capital has allowed it to build a strong track record and reputation over more than two decades[1][2][3][5].
Accolade Partners rides the trend of increasing institutional interest in private markets, particularly venture capital and growth equity, which have become critical for funding innovation in technology and healthcare. The firm’s timing is advantageous as startups and growth companies increasingly rely on private capital to scale before going public. Market forces such as technological disruption, healthcare innovation, and blockchain adoption create a fertile environment for Accolade’s investment strategies. By channeling capital to top fund managers and emerging sectors, Accolade influences the broader ecosystem by enabling startups to access growth capital and by supporting the development of new technologies and business models[1][2][4].
Looking ahead, Accolade Partners is likely to continue expanding its dedicated fund strategies, particularly in venture capital and blockchain, to capitalize on evolving market opportunities. Trends such as digital transformation, healthcare innovation, and decentralized technologies will shape its investment focus. The firm’s influence may grow as it leverages its network and expertise to identify emerging managers and companies with high growth potential. Accolade’s thoughtful portfolio construction and selective approach position it well to deliver strong returns while supporting innovation in critical sectors, maintaining its leadership role in the alternative investment space[1][2][3].
Key people at Accolade Partners.
